AI Analysis
AI-generated analysis. Always verify with the original filing.
Revenue remained nearly flat at $49.9M amid CBD headwinds, but gross profit and operating loss improvements reflect cost discipline and absence of prior-year inventory provisions, narrowing losses despite ongoing cash burn.
Key Takeaways
1Revenue of $49.9M, up 46.3% from $49.7M prior year as volume and mix factors influenced topline stability.
2Gross profit increased to $21.7M from $21.3M (2.1% YoY) with 43.5% margin, benefiting from factors like product mix and no repeat inventory provisions.
3Operating loss narrowed 36.6% to -$20.3M from -$32.0M, driven by cost containment in selling, general, and administrative expenses.
4Net loss improved slightly to -$29.7M from -$29.8M (35.2% YoY) with EPS stable at -$0.19.
5Operating cash flow burn reduced to -$14.1M from -$21.3M, reflecting efficiencies offsetting persistent losses.
6Management expects continued SG&A cost containment into 2026 from prior actions, supporting 12-month liquidity.